Little Rock – A leading OB/GYN at the University of Arkansas for Medical Sciences (UAMS) says the recent renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) could help women receive more comprehensive care.
Why the name change matters
Dr. Kathryn Stambough explained that the old name “PCOS” often misled patients into thinking the condition was solely about ovarian cysts. “The name PCOS was a bit of a misnomer and gave patients the idea that they were walking around with a bunch of cysts on their ovary,” she said.
The new terminology, PMOS, is intended to reflect the condition’s broader impact on metabolic health, including risks for diabetes, pre‑diabetes, high blood pressure, and cholesterol issues. By emphasizing the metabolic component, clinicians hope to diagnose and treat patients earlier and more holistically.
Broader approach to diagnosis and treatment
According to Dr. Stambough, the shift away from an ultrasound‑focused diagnosis encourages doctors to look beyond the ovary and consider a patient’s overall metabolic profile. “We want to be intentional about the care of the metabolic health of a patient with PMOS,” she said. This includes regular screening for blood‑sugar levels, blood pressure, and lipid panels, alongside traditional gynecologic assessments.
Symptoms of PMOS can overlap with other conditions, which sometimes delays diagnosis. Common signs include irregular menstrual cycles, acne, facial hair growth, and weight gain that is difficult to lose. The disorder also shows a strong association with anxiety and depression, adding another layer of complexity to patient care.
Impact on patients already diagnosed with PCOS
For women who have lived with a PCOS diagnosis, the new name signals a broader treatment plan. “The name change underscores a broader approach to care beyond ovarian imaging,” Dr. Stambough noted. Patients can expect more attention to lifestyle factors, nutrition, and metabolic monitoring, which may improve long‑term health outcomes.
Looking ahead
Dr. Stambough believes that as the medical community adopts the PMOS terminology, research and public awareness will follow suit, leading to better resources for women and families. “When we’re able to talk about a patient’s metabolic health and address the underpinnings of what’s going on, we can better care for patients,” she said.
The name change is still recent, but UAMS clinicians are already incorporating the new language into patient education materials and clinical guidelines. The hope is that a clearer, more accurate label will reduce confusion, promote earlier detection, and ultimately improve the quality of life for the estimated one‑in‑eight women worldwide affected by the condition.
Original reporting: KATV Little Rock (local) — read the source article.
